Doravirine-Islatravir (Idvynso)
Dr. Brian Wood reviews the mechanism of action, clinical trial data, and recommendations for use of the combination tablet doravirine-islatravir for HIV treatment. Including what is known and still unknown about the effects of various NRTI resistance medications on activity of the treatment.
▶︎
Introduction to Antiretroviral Therapy
▶︎
This New Histamine Treatment Helped 89% of Patients
▶︎
Histoplasmosis: Prophylaxis and Treatment in People with HIV
▶︎
Switching ART Regimens: A Discussion
▶︎
'CANCER OCCURRED near injection sites...': Bombshell testimony ‘EXPOSES’ COVID-19 vaccine injuries
▶︎
1986: How to Spot the Upper Class | That's Life! | BBC Archive
▶︎
'Antidepressants are like alcohol or cannabis' | Joanna Moncrieff
▶︎
The Lethal Drug Trial That Turned Men Into Elephants
▶︎
Colin Farrell Opens Up About His Son With Angelman Syndrome | PEOPLE
▶︎
CROI 2025: Four More Potentially Practice-Changing Abstracts
▶︎
Watch Ukrainian Drones OBLITERATE a Russian Jet
▶︎
The Bob Newhart Toupee Sketch That Broke Dean Martin
▶︎
It's NOT Memory - 5 Early Dementia Signs Everyone Misses
▶︎
ADD/ADHD | What Is Attention Deficit Hyperactivity Disorder?
▶︎
Ancient Human Species We Once Co-Existed With
▶︎
Mini-Lecture Series: Guideline Update: HHS Adult & Adolescent Antiretroviral Treatment Guidelines
▶︎
The French Do Not Care About Work
▶︎
LATITUDE Study: Interim Findings and Implications
▶︎
Priority Immunizations for People with HIV
▶︎